Dysphagia Management Market, By Product (Drugs (Proton Pump Inhibitors), Feeding Tubes (Naso-Gastric, Tubes PEG tubes), Nutritional Solutions (Thickeners, Beverages, Purees)), By Indication (Oropharangeal Dysphagia, Esophageal Dysphagia), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Specialty Clinics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
Difficulty in swallowing foods or liquids is termed as dysphagia. Dysphagia management involves use of food texture altering products and other products such as tubes to ease the process of swallowing. Dysphagia is caused due to oral, esophageal or oropharyngeal cancer and is more common in patient suffering from stroke. Increasing prevalence of throat cancer is expected to boost growth of the global dysphagia management market over the forecast period. Furthermore, increasing number of people addicted to smoking is also anticipated to increase the number of patient suffering from dysphagia which is expected to drive the growth of the market during the forecasted period.
Key features of the study:
This report provides in-depth analysis of the Dysphagia Management market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the global Dysphagia Management market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Eisai Co. Ltd., C. R. Bard, Inc. (Becton, Dickinson and Company), Hormel Health Labs, AstraZeneca, Cipla Ltd., Nestlé Health Science, Kent Precision Foods Group, Inc., Bracco Diagnostics Inc., Phagenesis Ltd., Nutricia Advanced Medical Nutrition, and Cook Medical Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global Dysphagia Management market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Dysphagia Management market
Detailed Segmentation:
Dysphagia Management Market, By Product:
Drugs
Proton Pump Inhibitors
Feeding Tubes
Naso-Gastric Tubes
PEG tubes
Nutritional Solutions
Thickeners
Beverages
Purees
Dysphagia Management Market, By Indication:
Oropharangeal Dysphagia
Esophageal Dysphagia
Dysphagia Management Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Specialty Clinics
Dysphagia Management Market, By Region:
North America
By Product:
Drugs
Proton Pump Inhibitors
Feeding Tubes
Naso-Gastric Tubes
PEG tubes
Nutritional Solutions
Thickeners
Beverages
Purees
By Indication
Oropharangeal Dysphagia
Esophageal Dysphagia
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Specialty Clinics
By Country:
U.S.
Canada
Latin America
By Product:
Drugs
Proton Pump Inhibitors
Feeding Tubes
Naso-Gastric Tubes
PEG tubes
Nutritional Solutions
Thickeners
Beverages
Purees
By Indication
Oropharangeal Dysphagia
Esophageal Dysphagia
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Specialty Clinics
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Product:
Drugs
Proton Pump Inhibitors
Feeding Tubes
Naso-Gastric Tubes
PEG tubes
Nutritional Solutions
Thickeners
Beverages
Purees
By Indication
Oropharangeal Dysphagia
Esophageal Dysphagia
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Specialty Clinics
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Product:
Drugs
Proton Pump Inhibitors
Feeding Tubes
Naso-Gastric Tubes
PEG tubes
Nutritional Solutions
Thickeners
Beverages
Purees
By Indication
Oropharangeal Dysphagia
Esophageal Dysphagia
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Specialty Clinics
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Product:
Drugs
Proton Pump Inhibitors
Feeding Tubes
Naso-Gastric Tubes
PEG tubes
Nutritional Solutions
Thickeners
Beverages
Purees
By Indication
Oropharangeal Dysphagia
Esophageal Dysphagia
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Specialty Clinics
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product:
Drugs
Proton Pump Inhibitors
Feeding Tubes
Naso-Gastric Tubes
PEG tubes
Nutritional Solutions
Thickeners
Beverages
Purees
By Indication
Oropharangeal Dysphagia
Esophageal Dysphagia
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Specialty Clinics
By Country:
South Africa
Central Africa
North Africa
Company Profiles
Eisai Co. Ltd. *
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
C. R. Bard, Inc. (Becton, Dickinson and Company)
Hormel Health Labs
AstraZeneca
Cipla Ltd.
Nestlé Health Science
Kent Precision Foods Group, Inc.
Bracco Diagnostics Inc.
Phagenesis Ltd.
Nutricia Advanced Medical Nutrition
Cook Medical Inc.
“*” marked represents similar segmentation in other categories in the respective section.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook